Lisa Decker
Direttore/Membro del Consiglio presso CHIMERIX, INC.
Patrimonio netto: 500 042 $ in data 31/05/2024
Profilo
Lisa L.
Decker is an Independent Director at Chimerix, Inc. since 2023 and the Chief Business Officer at IGM Biosciences, Inc. since 2021.
Previously, she worked as the Associate Director-Technology Licensing at UMass Chan Medical School from 2000 to 2008.
From 2008 to 2019, she served as the Vice President-Business Development at Nektar Therapeutics.
She then became the Chief Business Officer at Atreca, Inc. from 2019 to 2021.
Dr. Decker completed her undergraduate degree at the College of the Holy Cross (Massachusetts) and obtained a doctorate from Tufts University School of Medicine in 1998.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
IGM BIOSCIENCES, INC.
0.18% | 14/06/2024 | 60 029 ( 0.18% ) | 500 042 $ | 31/05/2024 |
CHIMERIX, INC.
-.--% | 20/06/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Lisa Decker
| Società | Posizione | Inizio |
|---|---|---|
| IGM BIOSCIENCES, INC. | Corporate Officer/Principal | 15/03/2021 |
| CHIMERIX, INC. | Direttore/Membro del Consiglio | 28/12/2023 |
Precedenti posizioni note di Lisa Decker
| Società | Posizione | Fine |
|---|---|---|
| ATRECA, INC. | Corporate Officer/Principal | 01/03/2021 |
| NEKTAR THERAPEUTICS | Corporate Officer/Principal | 01/06/2019 |
| UMass Chan Medical School | Corporate Officer/Principal | 01/08/2008 |
Formazione di Lisa Decker
| Tufts University School of Medicine | Doctorate Degree |
| College of the Holy Cross (Massachusetts) | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| IGM BIOSCIENCES, INC. | Health Technology |
| CHIMERIX, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Atreca, Inc.
 Atreca, Inc. BiotechnologyHealth Technology Atreca, Inc. operates as a clinical-stage biopharmaceutical company, which engages in developing novel antibody-based therapeutics to treat a range of solid tumor types. Its technology leverages next-generation sequencing to identify the set of functional antibodies produced in patients during an immune response. The company was founded by Robert Axtell, Guy Cavet, Jeremy Sokolove, Tito A. Serafini, Paulette A. Dillon, Daniel Emerling, Wayne Volkmuth, Jonathan Woo, Yann Chong Tan, William H. Robinson and Lawrence J. Steinman on June 11, 2010 and is headquartered in San Carlos, CA. | Health Technology |
- Borsa valori
- Insiders
- Lisa Decker
